Preliminary application of ascorbate-rich dialysate on ameliorating oxidative stress in maintenance hemodialysis patients

Feng DING,Xue-feng SHI,Yong GU,Qiu-yu ZHU,Jun XUE,Shan-yan LIN

DOI: https://doi.org/10.3969/j.issn.1672-8467.2006.02.005

2006-01-01

Abstract:Purpose To observe the effects of ascorbate (vitamin C, Vit C) dialysate on oxidative stress in maintenance hemodialysis (MHD) patients, particularly in comparison with those of intravenous ascorbate supplementation. Methods (1) Single dialysis session: 8 MHD patients performed three successive dialysis sessions, and each course was taken as a group. They were respectively] 1control group; 2iv-AA group; 3D-AA group(using ascorbate-containing acid dialysate of 2 g/L). Blood samples were drawn every hour during each course for determining plasma total ascorbic acid (TAA), ratio of dehydroascorbic acid(DHAA) to TAA(DHAA/TAA), vitamin E(Vit E), malondialdehyde(MDA) in both plasma and erythrocytes. (2) 4-week application of ascorbate-rich dialysate : Twenty-four MHD patients were randomly divided into control group(n= 12) and experimental group (n= 11 with use of acid dialysate containing ascorbic acid 0. 8 g/L). The above-mentioned oxidative stress markers, oxidized low density lipoprotein (oxLDL), advanced oxidation protein products (AOPP), serum C-reactive protein(CRP), serum ferritin(SF) and hematological indices were examined before and after the 4-week period. Results (1) Plasma TAA gradually decreased during the course of dialysis in control group meanwhile MDA showed a moderate and significant increase[ postdialysis (8. 47 ± 3. 45) μmol/L vs pre-dialysis (5. 12 ± 1. 15) μmol/L,P<0. 05]. A TAA concentration peak protruded in the curve right after injection of ascorbic acid, accompanied by dramatic reduction of DHAA/TAA. However, a precipitous fall of TAA soon followed and ultimately reverted to the similar level at the beginning of dialysis. Plasma TAA concentration remained table and VitE level slightly elevated in D-AA group[post-dialysis (26. 7 ± 2. 8) μmol/L vs pre-dialysis (22. 4 ± 0. 9) μmol/ L, P<0. 001]. (2) Plasma TAA augmented in experimental group at the end of the 4-week investigation[at the end (83. 8 ± 56. 5) μmol/L vs at the start (32. 6 ± 25. 2) μmol/L, P<0. 05], and plasma oxLDL value became lower in the experimental group. Conclusions Plenty of plasma ascorbic acid losses in hemodialysis while oxidative stress is exacerbated. Ascorbic acid supplementation via either intravenous injection or extracorporeal circuit will alleviate loss of this antioxidant and help attenuate oxidative stress. but internal exquisite change will probably be avoided only by the latter means.